US Physical Therapy (USPH) Misses Q3 EPS by 1c; offers guidance
Tweet
Share
E-mailGet Alerts USPH Hot Sheet
Price: $78.71 -0.81%
EPS Growth %: +16.7%
Financial Fact:
Net income attributable to common shareholders: 5.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +16.7%
Financial Fact:
Net income attributable to common shareholders: 5.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
US Physical Therapy (NYSE: USPH) reported Q3 EPS of $0.66, $0.01 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $197.13 million versus the consensus estimate of $194.05 million.
2025 EARNINGS GUIDANCE
Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million, reflecting third-quarter results and the Company’s current expectations for the remainder of the year.
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- BMO Capital Starts American Eagle Outfitters (AEO) at Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
